[{"id":"4b22131b-479c-418d-9460-87ca3133481d","acronym":"","url":"https://clinicaltrials.gov/study/NCT00792701","created_at":"2021-01-18T03:00:30.679Z","updated_at":"2024-07-02T16:36:49.078Z","phase":"Phase 2","brief_title":"S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT00792701","lead_sponsor":"Southwest Oncology Group","biomarkers":" ERCC1 • RRM1","pipe":" | ","alterations":" ERCC1 expression • RRM1 expression","tags":["ERCC1 • RRM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ERCC1 expression • RRM1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • gemcitabine"],"overall_status":"Completed","enrollment":" Enrollment 85","initiation":"Initiation: 11/01/2008","start_date":" 11/01/2008","primary_txt":" Primary completion: 04/01/2016","primary_completion_date":" 04/01/2016","study_txt":" Completion: 04/01/2016","study_completion_date":" 04/01/2016","last_update_posted":"2020-03-06"},{"id":"270f6c2c-c1ee-4f28-b87f-f30b7453ad9c","acronym":"MADe IT","url":"https://clinicaltrials.gov/study/NCT00215930","created_at":"2021-01-18T00:43:55.513Z","updated_at":"2024-07-02T16:37:24.162Z","phase":"Phase 2","brief_title":"The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT00215930 - MADe IT","lead_sponsor":"H. Lee Moffitt Cancer Center and Research Institute","biomarkers":" ERCC1 • RRM1","pipe":" | ","alterations":" ERCC1 expression • RRM1 expression","tags":["ERCC1 • RRM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ERCC1 expression • RRM1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • gemcitabine • docetaxel • vinorelbine tartrate"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 02/01/2004","start_date":" 02/01/2004","primary_txt":" Primary completion: 10/01/2009","primary_completion_date":" 10/01/2009","study_txt":" Completion: 10/01/2009","study_completion_date":" 10/01/2009","last_update_posted":"2017-03-23"},{"id":"fc18a3b4-d245-4d27-ba5a-baa9f7f17ef0","acronym":"","url":"https://clinicaltrials.gov/study/NCT01194453","created_at":"2021-01-18T04:46:49.793Z","updated_at":"2024-07-02T16:37:31.280Z","phase":"Phase 2","brief_title":"Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer","source_id_and_acronym":"NCT01194453","lead_sponsor":"Sun Yat-sen University","biomarkers":" TYMS • RRM1","pipe":" | ","alterations":" TYMS expression","tags":["TYMS • RRM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TYMS expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • gemcitabine • pemetrexed • dexamethasone"],"overall_status":"Completed","enrollment":" Enrollment 288","initiation":"Initiation: 11/01/2009","start_date":" 11/01/2009","primary_txt":" Primary completion: 09/01/2010","primary_completion_date":" 09/01/2010","study_txt":" Completion: 08/01/2012","study_completion_date":" 08/01/2012","last_update_posted":"2016-06-16"}]